DOI QR코드

DOI QR Code

Dynamic Kinetic Resolution of L-Threonine-derived α-Bromo Esters for Asymmetric Synthesis of α-Amino Esters

  • 투고 : 2013.08.30
  • 심사 : 2013.10.08
  • 발행 : 2014.01.20

초록

키워드

Experimental

General Procedure for the Asymmetric Nucleophilic Substitution via Dynamic Kinetic Resolution. To a solution of L-threonine-derived α-bromo ester (1-7) in CH2Cl2(ca. 0.1 M) at rt were added DIEA (1.0 equiv), TBAI (1.0 equiv) and an amine nucleophile (1.2 equiv). After the resulting reaction mixture was stirred at room temperature for 12-24 h, the solvent was evaporated and the crude material was purified by column chromatography to give a α-amino ester. The drs of 8a-u were determined by 1H NMR integration of hydrogens of two diastereomers and the ers of 9 and 10 were determined by CSP-HPLC.

N-Acetyl-O-(α-(p-methoxyanilino)phenylacetyl)-L-threonine Isopropyl Ester (8a). 63% yield; 1H NMR (CDCl3, 400 MHz, major epimer) δ 7.44-7.30 (m, 5H), 6.72 (d, J = 8.8 Hz, 2H), 6.54 (d, J = 8.8 Hz, 2H), 6.20 (d, J = 9.2 Hz, 1H), 5.40 (m, 1H), 4.98 (s, 1H), 4.94 (m, 1H), 4.77 (m, 1H), 3.69 (s, 3H), 2.01 (s, 1H), 1.22 (d, J = 6.0 Hz, 3H), 1.06 (m, 6H); 13C NMR (CDCl3, 100 MHz, major epimer) δ 170.9, 170.4, 169.2, 152.7, 140.2, 137.4, 128.9, 128.5, 127.3, 127.2, 114.8, 72.2, 70.0, 61.8, 55.7, 55.4, 23.1, 21.7, 21.5, 16.4.

N-Pivaloyl-O-(α-(p-methoxyanilino)phenylacetyl)-L-threonine Isopropyl Ester (8b). 64% yield; 1H NMR (CDCl3, 400 MHz, major epimer) δ 7.45-7.26 (m, 5H), 6.71 (d, J = 8.8 Hz, 2H), 6.54 (d, J = 8.8 Hz, 2H), 6.15 (d, J = 9.2 Hz, 1H), 5.41 (m, 1H), 4.99 (m, 1H), 4.94 (s, 1H), 4.72 (m, 1H), 3.69 (s, 3H), 1.25 (m, 3H), 1.19 (s, 9H), 1.12 (m, 3H), 1.02 (m, 3H); 13C NMR (CDCl3, 100 MHz, major epimer) δ 178.7, 170.8, 169.2, 152.7, 140.1, 137.6, 128.9, 128.4, 127.2, 121.9, 114.8, 72.7, 69.8, 61.8, 55.6, 55.2, 38.8, 27.4, 21.7, 21.5, 16.2.

N-Boc-O-(α-(p-methoxyanilino)phenylacetyl)-L-threonine Isopropyl Ester (8c). 58% yield; 1H NMR (CDCl3, 400 MHz, major epimer) δ 7.44-7.30 (m, 5H), 6.72 (d, J = 8.8 Hz, 2H), 6.52 (d, J = 8.8 Hz, 2H), 5.42 (m, 1H), 5.15 (d, J = 9.6 Hz, 1H), 4.93 (m, 2H), 4.50 (m, 1H), 4.38 (m, 1H), 3.69 (s, 3H), 1.50 (s, 9H), 1.24 (m, 3H), 1.08 (m, 6H); 13C NMR (CDCl3, 100 MHz, major epimer) δ 170.9, 169.3, 155.8, 152.6, 140.2, 137.3, 128.9, 128.4, 127.2, 114.8, 80.2, 72.5, 69.8, 61.7, 57.2, 55.7, 28.8, 21.7, 21.5, 16.3.

N-Benzoyl-O-(α-(p-methoxyanilino)phenylacetyl)-L-threonine Isopropyl Ester (8d). 62% yield; 1H NMR (CDCl3, 400 MHz, major epimer) δ 7.55-7.26 (m, 10H), 6.70 (d, J = 8.8 Hz, 2H), 6.53 (d, J = 8.8 Hz, 2H), 5.49 (m, 1H), 5.02-4.95 (m, 3H), 4.57 (m, 1H), 3.68 (s, 3H), 1.25 (d, J= 6.0 Hz, 3H), 1.15 (m, 6H); 13C NMR (CDCl3, 100 MHz, major epimer) δ 171.0, 169.1, 167.6, 152.7, 140.2, 137.6, 133.7, 132.0, 128.9, 128.7, 128.4, 127.3, 127.2, 114.9, 114.7, 72.7, 70.1, 61.9, 55.9, 55.7, 21.8, 21.6, 16.6.

N-(p-Methoxybenzoyl)-O-(α-(p-methoxyanilino)phenyl acetyl)-L-threonine Isopropyl Ester (8e). 86% yield; 1H NMR (CDCl3, 400 MHz, major epimer) δ 7.69 (d, J = 8.8 Hz, 2H), 7.48-7.26 (m, 5H), 6.93 (d, J = 8.8 Hz, 2H), 6.71 (d, J = 8.8 Hz, 2H), 6.53 (d, J = 8.8 Hz, 2H), 5.47 (m, 1H), 5.02-4.94 (m, 3H), 4.59 (br, 1H), 3.85 (s, 3H), 3.68 (s, 3H), 1.25 (m, 3H), 1.15 (m, 6H); 13C NMR (CDCl3, 100 MHz, major epimer) δ 178.7, 170.8, 169.2, 152.7, 140.1, 137.6, 129.9, 128.9, 128.4, 127.8, 127.2, 121.9, 114.8, 114.7, 72.7, 69.8, 61.8, 55.6, 55.2, 21.7, 21.5, 16.2.

N-(2-pyridinylcarbonyl)-O-(α-(p-methoxyanilino)phenylacetyl)-L-threonine Isopropyl Ester (8f). 62% yield; 1H NMR (CDCl3, 400 MHz, major epimer) δ 8.67 (m, 2H), 8.18 (m, 1H), 7.86 (m, 1H), 7.50-7.26 (m, 5H), 6.70 (d, J = 8.8 Hz, 2H), 6.53 (d, J = 8.8 Hz, 2H), 5.54 (m, 1H), 5.05-4.92 (m, 3H), 4.57 (m, 1H), 3.69 (s, 3H), 1.24 (d, J = 6.0 Hz, 3H), 1.10 (m, 6H); 13C NMR (CDCl3, 100 MHz, major epimer) δ 170.9, 168.8, 164.7, 152.6, 148.4, 140.2, 140.0, 139.9, 137.4, 128.8, 128.3, 127.2, 126.6, 122.5, 116.4, 114.9, 72.3, 70.0, 61.8, 55.7, 55.6, 21.7, 21.5, 16.5.

N,N-Dibenzyl-O-(α-(p-methoxyanilino)phenylacetyl)-L-threonine Isopropyl Ester (8g). 66% yield; 1H NMR (CDCl3, 400 MHz, major epimer) δ 7.38-7.21 (m, 15H), 6.71 (d, J = 8.8 Hz, 2H), 6.50 (d, J = 8.8 Hz, 2H), 5.43 (m, 1H), 5.10 (m, 1H), 4.98 (d, J = 5.6 Hz, 1H), 4.70 (d, J = 6.0 Hz, 1H), 4.03 (d, J = 13.6 Hz, 2H), 3.69 (s, 3H), 3.59 (d, J = 13.6 Hz, 2H), 3.36 (d, J = 7.6 Hz, 1H), 1.31 (d, J = 6.0 Hz, 3H), 1.22 (d, J = 6.0 Hz, 3H), 0.93 (d, J = 6.4 Hz, 3H); 13C NMR (CDCl3, 100 MHz, major epimer) δ 171.1, 169.3, 152.5, 140.3, 139.3, 137.8, 129.0, 128.8, 128.4, 128.1, 127.2, 114.9, 114.7, 70.2, 68.5, 64.7, 61.9, 55.7, 55.4, 22.3, 22.0, 17.0.

N,N-Dibenzyl-O-(α-(o-methoxyanilino)phenylacetyl)-L-threonine Isopropyl Ester (8m). 67% yield; 1H NMR (CDCl3, 400 MHz, major epimer) 7.40-7.23 (m, 15H), 6.78- 6.32 (m, 4H), 5.55 (d, J = 5.2 Hz, 1H), 5.45 (m, 1H), 5.11 (m, 1H), 5.04 (d, J = 5.2 Hz, 1H), 4.03 (d, J = 13.6 Hz, 2H), 3.82 (s, 3H), 3.61 (d, J = 13.6 Hz, 2H), 3.36 (d, J = 7.2 Hz, 1H), 1.31 (d, J = 6.4 Hz, 3H), 1.20 (d, J = 6.4 Hz, 3H), 0.95 (d, J = 6.4 Hz, 3H); 13C NMR (CDCl3, 100 MHz, major epimer) δ 170.9, 169.3, 147.1, 139.5, 139.3, 137.7, 136.1, 129.1, 128.9, 128.8, 128.7, 128.3, 128.1, 127.6, 127.2, 127.0, 121.0, 117.2, 110.7, 109.5, 70.3, 68.4, 64.7, 61.0, 55.4, 55.3, 22.3, 22.0, 17.0.

N,N-Dibenzyl-O-(α-(diphenylmethylamino)phenyl acetyl)-L-threonine isopropyl ester (8n). 67% yield; 1H NMR (CDCl3, 400 MHz, major epimer) 7.49-7.17 (m, 25H), 5.60 (s, 1H), 5.45 (m, 1H), 5.11 (m, 1H), 4.81 (s, 1H), 3.95 (d, J = 13.6 Hz, 2H), 3.51 (d, J = 13.6 Hz, 2H), 3.26 (d, J = 6.4 Hz, 1H), 1.33 (d, J = 6.4 Hz, 3H), 1.24 (d, J = 6.4 Hz, 3H), 0.94 (d, J = 6.4 Hz, 3H); 13C NMR (CDCl3, 100 MHz, major epimer) δ 172.4, 169.3, 143.3, 139.3, 129.2, 128.8, 128.7, 128.6, 128.3, 127.8, 127.7, 127.6, 127.5, 127.2, 69.4, 68.4, 64.8, 64.2, 63.0, 55.4, 22.4, 22.1, 17.1.

N,N-Dibenzyl-O-(α-((R)-phenethylamino)phenyl acetyl)-L-threonine Isopropyl Ester (8o). 54% yield; 1H NMR (CDCl3, 400 MHz, major epimer) 7.31-7.15 (m, 20H), 5.38 (m, 1H), 5.08 (m, 1H), 4.19 (s, 1H), 3.93 (d, J = 13.6 Hz, 2H), 3.57 (m, 1H), 3.49 (d, J = 13.6 Hz, 2H), 3.22 (d, J = 8.0 Hz, 1H), 1.36 (d, J = 6.4 Hz, 3H), 1.30 (d, J = 6.4 Hz, 3H), 1.21 (d, J = 6.4 Hz, 3H), 0.90 (d, J = 6.4 Hz, 3H); 13C NMR (CDCl3, 100 MHz, major epimer) δ 171.9, 169.2, 139.3, 129.0, 128.7, 128.5, 128.2, 127.9, 127.7, 127.2, 127.0, 126.8, 69.1, 68.2, 64.7, 62.6, 55.2, 54.3, 24.7, 22.2, 22.0, 17.0.

N,N-Dibenzyl-O-(α-(benzylamino)phenylacetyl)-L-threonine Isopropyl Ester (8p). 71% yield; 1H NMR (CDCl3, 400 MHz, major epimer) 7.24-7.14 (m, 20H), 5.36 (m, 1H), 5.01 (m, 1H), 4.28 (s, 1H), 3.92 (d, J = 13.6 Hz, 2H), 3.69 (m, 2H), 3.48 (d, J = 13.6 Hz, 2H), 3.22 (d, J = 7.2 Hz, 1H), 2.32 (br, 1H), 1.30 (d, J = 6.4 Hz, 3H), 1.15 (d, J = 6.4 Hz, 3H), 0.92 (d, J = 6.4 Hz, 3H); 13C NMR (CDCl3, 100 MHz, major epimer) 172.2, 169.4, 139.7, 139.4, 138.1, 129.1, 128.7, 128.6, 128.3, 128.0, 127.6, 127.2, 127.1, 69.7, 68.4, 64.7, 64.6, 55.5, 51.3, 22.3, 22.1, 17.2.

N,N-Dibenzyl-O-(α-(3,4-dihydro-2(1H)-isoquinolinyl)phenylacetyl)-L-threonine Isopropyl Ester (8q). 66% yield; 1H NMR (CDCl3, 400 MHz, major epimer) 7.28-6.88 (m, 19H), 5.44 (m, 1H), 5.06 (m, 1H), 4.14 (s, 1H), 4.08 (d, J= 13.6 Hz, 2H), 3.75-3.62 (m, 4H), 3.34 (d, J = 6.8 Hz, 1H), 2.84-2.79 (m, 4H), 1.32 (d, J = 6.4 Hz, 3H), 1.22 (d, J = 6.4 Hz, 3H), 0.98 (d, J = 6.4 Hz, 3H); 13C NMR (CDCl3, 100 MHz, major epimer) 170.7, 169.5, 139.4, 136.0, 134.4, 134.3, 129.0, 128.8, 128.7, 128.6, 128.3, 128.2, 127.1, 126.7, 126.2, 125.6, 73.8, 69.9, 68.3, 64.6, 55.5, 53.4, 48.5, 28.9, 22.2, 22.0, 17.0.

N,N-Dibenzyl-O-(α-(dibenzylamino)phenylacetyl)-L-threonine Isopropyl Ester (8r). 73% yield; 1H NMR (CDCl3, 400 MHz, major epimer) δ 7.28-7.16 (m, 25H), 5.58 (m, 1H), 5.11 (m, 1H), 4.59 (s, 1H), 3.95 (d, J = 13.6 Hz, 2H), 3.88 (d, J = 13.6 Hz, 2H), 3.66 (d, J = 13.6 Hz, 2H), 3.58 (d, J = 13.6 Hz, 2H), 3.30 (d, J = 6.4 Hz, 1H), 1.32 (d, J = 6.4 Hz, 3H), 1.24 (d, J = 6.4 Hz, 3H), 1.14 (d, J = 6.4 Hz, 3H); 13C NMR (CDCl3, 100 MHz, major epimer) δ 171.5, 169.6, 139.6, 139.4, 139.3, 136.2, 129.1, 128.9, 128.3, 128.2, 127.0, 69.8, 68.3, 66.1, 64.5, 55.7, 54.0, 22.3, 22.0, 17.5.

N,N-Dibenzyl-O-(α-(benzylmethylamino)phenylacetyl)-L-threonine Isopropyl Ester (8s). 67% yield; 1H NMR (CDCl3, 400 MHz, major epimer) δ 7.42-7.20 (m, 20H), 5.45 (m, 1H), 4.98 (m, 1H), 4.23 (s, 1H), 4.10 (d, J = 13.6 Hz, 2H), 3.67 (d, J = 13.6 Hz, 2H), 3.60 (d, J = 13.6 Hz, 1H), 3.51 (d, J = 13.6 Hz, 1H), 3.34 (d, J = 6.4 Hz, 1H), 2.20 (s, 3H), 1.28 (d, J = 6.0 Hz, 3H), 1.13 (d, J = 6.4 Hz, 3H), 1.06 (d, J = 6.4 Hz, 3H); 13C NMR (CDCl3, 100 MHz, major epimer) 171.0, 169.5, 139.5, 139.0, 136.5, 129.0, 128.9, 128.8, 128.5, 128.3, 128.1, 127.1, 127.0, 73.1, 70.1, 68.2, 64.5, 58.7, 55.5, 39.4, 22.2, 21.9, 17.1.

N,N-Dibenzyl-O-(α-(dibutylamino)phenylacetyl)-L-threonine Isopropyl Ester (8t). 64% yield; 1H NMR (CDCl3, 400 MHz, major epimer) 7.34-7.18 (m, 15H), 5.49 (m, 1H), 5.04 (m, 1H), 4.52 (s, 1H), 4.07 (d, J = 13.6 Hz, 2H), 3.68 (d, J = 13.6 Hz, 2H), 3.35 (d, J = 6.4 Hz, 1H), 2.25 (m, 4H), 1.40- 1.10 (m, 17H), 0.80 (m, 6H); 13C NMR (CDCl3, 100 MHz, major epimer) δ 171.7, 169.6, 139.5, 137.4, 129.0, 128.3, 128.2, 127.7, 127.1, 70.0, 69.5, 68.2, 64.6, 55.6, 50.5, 29.8, 22.2, 22.0, 20.4, 17.3, 14.1.

N,N-Dibenzyl-O-(α-(o-aminoanilino)phenylacetyl)-L-threonine Isopropyl Ester (8u). 93% yield; 1H NMR (CDCl3, 400 MHz, major epimer) 7.34-7.21 (m, 15H), 6.71-6.44 (m, 4H), 5.44 (m, 1H), 5.09 (m, 1H), 5.02 (d, J = 13.6 Hz, 1H), 4.63 (br, 1H), 4.03 (d, J = 13.6 Hz, 2H), 3.61 (d, J = 13.6 Hz, 2H), 3.40 (br, 2H), 3.36 (d, J = 6.8 Hz, 1H), 1.32 (d, J = 6.4 Hz, 3H), 1.19 (d, J = 6.4 Hz, 3H), 0.95 (d, J = 6.4 Hz, 3H); 13C NMR (CDCl3, 100 MHz, major epimer) δ 171.2, 169.3, 139.3, 129.2, 129.0, 128.7, 128.6, 128.3, 127.2, 127.1, 120.5, 119.6, 116.9, 113.5, 70.4, 68.4, 64.6, 61.5, 55.4, 22.2, 22.0, 17.0.

N-(p-Methoxphenyl)phenylglycine Methyl Ester (9). 71% yield from 8d; 1H NMR (CDCl3, 400 MHz) δ 7.48-7.25 (m, 5H), 6.69 (d, J = 8.9 Hz, 2H), 6.52 (d, J = 8.9 Hz, 2H), 5.00 (s, 1H), 4.67 (br, 1H), 3.72 (s, 3H), 3.67 (s, 3H).1c Chiral HPLC: 87:13 er, tR (S)-major enantiomer, 76.2 min; tR (R)-minor enantiomer, 66.3 min (Chiralcel OJ-H column; 20% 2-propanol in hexane; 0.5 mL/min).

3-Phenyl-3,4-dihydro-1,4-quinoxalin-2-one (10). 83% yield; 1H NMR (CDCl3, 400 MHz) δ 7.95 (br, 1H), 7.43- 6.70 (m, 9H), 5.08 (s, 1H), 4.28 (br, 1H).1e Chiral HPLC: 92:8 er, tR (S)-major enantiomer, 45.0 min; tR (R)-minor enantiomer, 40.1 min (Chiralcel OJ-H column; 20% 2-propanol in hexane; 0.5 mL/min).

참고문헌

  1. (a) Ben, R. N.; Durst, T. J. Org. Chem. 1999, 64, 7700. https://doi.org/10.1021/jo9811625
  2. (b) Camps, P.; Perez, F.; Soldevilla, N.; Borrego, M. A. Tetrahedron: Asymmetry 1999, 10, 493. https://doi.org/10.1016/S0957-4166(99)00018-X
  3. (c) Kim, H. J.; Shin, E.-k.; Chang, J.-y.; Kim, Y.; Park, Y. S. Tetrahedron Lett. 2005, 46, 4115. https://doi.org/10.1016/j.tetlet.2005.04.003
  4. (d) Ammazzalorso, A.; Amoroso, R.; Bettoni, G.; De Filippis, B.; Fantacuzzi, M.; Giampietro, L.; Maccallini, C.; Tricca, M. L. Eur. J. Org. Chem. 2006, 4088.
  5. (e) Kim, Y.; Lee, M. H.; Choi, E. T.; No, E. S.; Park, Y. S. Heterocycles 2007, 71, 5. https://doi.org/10.3987/COM-06-10910
  6. (f) Jang, J. I.; Kang, S. Y.; Kang, K. H.; Park, Y. S. Tetrahedron 2011, 67, 6221. https://doi.org/10.1016/j.tet.2011.06.055
  7. (a) Lee, S.-k.; Nam, J.; Park, Y. S. Synlett 2002, 790.
  8. (b) Nam, J.; Lee, S.-k.; Park, Y. S. Tetrahedron 2003, 59, 2397. https://doi.org/10.1016/S0040-4020(03)00285-0
  9. (c) Kim, Y.; Kang, K. H.; Choi, E. T.; Lee, M. H.; Park, Y. S. Bull. Korean Chem. Soc. 2007, 28, 325. https://doi.org/10.5012/bkcs.2007.28.2.325
  10. Park, Y. S. Tetrahedron: Asymmetry 2009, 43, 8253.
  11. (a) Jiang, Q.; Jiang, D.; Jiang, Y.; Fu, H.; Zhao, Y. Synlett. 2007, 1836.
  12. (b) Tanimori, S.; Kashiwagi, H.; Nishimura, T.; Kirihata, M. Adv. Synth. Catal. 2010, 352, 2531. https://doi.org/10.1002/adsc.201000323
  13. (c) Rueping, M.; Tato, F.; Schoepke, F. R. Chem. Eur. J. 2010, 16, 2688. https://doi.org/10.1002/chem.200902907

피인용 문헌

  1. Synthesis of 1- and 4-substituted piperazin-2-ones via Jocic-type reactions with N-substituted diamines vol.13, pp.8, 2015, https://doi.org/10.1039/C4OB02311K
  2. Stereoselective Substitution of Configurationally Labile α‐Bromo Aryl­acetates with Amines and Az­lactones by L‐Threonine‐Mediated Crystallization‐ vol.2016, pp.14, 2014, https://doi.org/10.1002/ejoc.201600201